Autopsy report · NCT02053597

TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.

“due to evolving scientific knowledge in the field that would make the questions being addressed in the trial less relevant”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Jules Bordet Institute
Sponsor type: University, hospital or other
Conditions: Breast Cancer
Interventions: Doxorubicin; paclitaxel
Participants: 0
Sites: 4
Countries: Belgium

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.